• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Over-regulation partly to blame for ‘wildly expensive’ research costs, says medical executive

by February 14, 2025
written by February 14, 2025

While the debate over President Donald Trump’s cuts to facilities and administrative costs associated with federally funded research grants rages on, one expert in the field of medicine says he sees a clear way forward. 

Dr. David Skorton, president and CEO of the Association of American Medical Colleges, has had a wide-ranging career spanning government, higher education and medicine. He now runs a national association that oversees all Medical Doctorate-granting schools in the country, and about 500 academic health systems teaching hospitals. Skorton told Fox News Digital that while he does not agree with Trump’s blanket cuts, the current status quo needs changing. He cited over-regulation as a reason why facilities and administrative costs have gotten so ‘wildly expensive.’ 

He also said that transparency from research institutions could help create better awareness of how taxpayer dollars are being used to support those institutions that have become the bane of critics who say they are stockpiling taxpayer dollars for their own benefit. 

‘In some cases, more than one agency will develop regulations, and the researchers have to answer to all of those different agency regulations. We should be able to harmonize those things and come out with a more thoughtful approach to reducing some of the regulatory burden,’ Skorton said. He added that, in turn, researchers will be able to spend more time doing what they do best, research, which in the long run will mean greater results for the public.   

‘It would also mean that the costs would go down because the additional personnel, the additional things that are necessary to keep track of things for these regulations, that would also go down,’ Skorton pointed out.

Skorton said that the impact of reducing over-regulation will be two-fold: it will improve the current research environment and show that there is room for collaboration to reduce overhead costs while not threatening new research. In particular, he pointed to research involving human or animal subjects, which Skorton said is often riddled with regulatory requirements that, while important, could be streamlined.  

Skorton added that the AAMC was ‘very hungry’ to work with the administration on improving this framework, noting that ‘we’re not here to claim that the status quo is perfect, and we want to defend it, but the idea of very quickly knocking down the facilities and administrative costs to what felt like an arbitrary number to many of us, 15%, will cause research to be reduced.’

The AAMC president said there is an onus on research institutions as well to better educate folks about where their taxpayer dollars are going when they are utilized by federally funded research programs.

‘For every dollar that we get at universities, medical schools, et cetera, for research from the NIH or some other science agency, for every dollar another half dollar, roughly, is contributed by the institution,’ Skorton pointed out. ‘That’s something that maybe people don’t realize, and why would they, because we have to be more clear in making that visible, that we already contribute a lot to the research.’

Fox News Digital spoke to medical experts who have supported Trump’s blanket cut to administrative and facilities costs, and they argue that reducing this price burden on the federal government will increase the availability of new research grants, while getting rid of financial bloat that universities have been able to take advantage of at the taxpayers’ expense.

One of the doctors who shared their thoughts, Dr. Erika Schwartz, echoed calls for reform to the current structure, similar to Skorton.  

‘While infrastructure support is necessary, there’s room for more efficient cost management. A reformed funding model could redirect more resources to direct research activities while maintaining essential support services,’ Schwartz said. ‘This could potentially increase the number of funded research projects and accelerate medical breakthroughs, ultimately benefiting patients more directly.’

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump’s ‘two sexes’ order spurs state-level efforts to crack down on trans treatments for minors
next post
Federal judge delays Labor Department’s request to block DOGE access

related articles

Judge dismisses 2020 election interference case against Trump,...

November 26, 2025

Appeals court upholds $1 million penalty against Trump...

November 26, 2025

Politician named Adolf Hitler becomes focal point of...

November 26, 2025

Trump touts ‘progress’ on Ukraine-Russia deal, admits it’s...

November 26, 2025

US envoy gave Russian aide tips on how...

November 26, 2025

FBI nabs Florida man with alleged plan to...

November 26, 2025

Republicans try to quash concerns of more exits...

November 25, 2025

Trump jokes that Biden turkey pardon in 2024...

November 25, 2025

‘Full-blown battle’ brewing in Dem party as Mamdani-style...

November 25, 2025

CCP-linked firms quietly hold stakes in US solar...

November 25, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • House GOP leaders scramble for Plan B after Trump, Musk lead conservative fury against spending bill

    December 19, 2024
  • A ‘man-made disaster’ could make it trickier to buy or sell a home in some areas this fall, real estate expert says

    August 26, 2024
  • Outgoing Treasury Sec. Yellen ‘sorry that we haven’t made more progress,’ believes deficit must be decreased

    December 11, 2024
  • Biden, Democrats back away from bill that would give Trump more federal judges to appoint

    December 11, 2024
  • ‘Nail in the coffin’: Grocer turned House lawmaker trashes Kamala Harris’ price control plan

    August 24, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,902)
  • Investing (634)
  • Stock (956)

Latest Posts

  • Russia, Ukraine agree to Black Sea ceasefire following US talks

    March 25, 2025
  • Trump FCC chair targets NPR, PBS for investigation ahead of Congressional threats to defund

    January 30, 2025
  • RFK Jr’s health agenda gains popularity among state lawmakers

    February 18, 2025

Recent Posts

  • Trump says Canada would have no tariffs as 51st state, as observers brace for trade war

    February 2, 2025
  • Trump blasts Harris as part of Truth Social flurry on what she ‘didn’t mention’ in DNC speech

    August 23, 2024
  • Dems threatening government shutdown over Elon Musk hate, Republicans say

    March 11, 2025

Editor’s Pick

  • Republicans say they’re ‘out of the loop’ on Trump’s $400M Qatari plane deal

    May 14, 2025
  • Trump accuses Senate Democrats of using nominee confirmations as leverage for funding deals

    August 4, 2025
  • Lucid CEO says Wall Street misinterpreted $1.75 billion capital raise

    October 22, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock